House Medicare Bill Expands Competitive Bidding To DME Infusion Products
This article was originally published in The Gray Sheet
Executive Summary
Device industry concerns that an expanded Medicare competitive bidding program would eventually include new, high-end technologies may be alleviated by language in the "Medicare Prescription Drug & Modernization Act" of 2003, which specifically excludes Class III devices